Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Brespal 125mg Capsule
Manufacturer/Marketed By : AUREATE HEALTHCARE PVT LTD
$93.84 $46.93
Brespal 125 mg is a targeted therapy containing palbociclib, a cyclin-dependent kinase inhibitor used mainly as Brespal for breast cancer in patients with hormone receptor-positive, HER2-negative advanced or metastatic disease....
PALBOCICLIB
Active Pharmaceutical Ingredient
Brespal 125mg Capsule
$93.84
$46.93
Brespal 125 mg is a targeted therapy containing palbociclib, a cyclin-dependent kinase inhibitor used mainly as Brespal for breast cancer in patients with hormone receptor-positive, HER2-negative advanced or metastatic disease. It is usually prescribed along with other anticancer medicines. Common side effects include nausea, vomiting, diarrhea, tiredness, hair loss, rash, infections, nose bleed, decreased appetite, low blood cell counts, and changes in vision or taste. Inform your doctor if these effects persist or worsen. Tell your healthcare provider if you are allergic to this medicine or have liver, kidney, or lung problems. Report any symptoms like fever, chills, sore throat, dry cough, chest pain, or breathing difficulty immediately. Effective birth control must be used during treatment and for at least three weeks after the last dose. If required, your doctor may recommend a suitable Brespal 125mg substitute. The Brespal 125mg price may differ depending on location and retailer.
Active Pharmaceutical Ingredient
Uses
• Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Brespal 125mg side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Tiredness
• Hair loss
• Dry skin, rash
• Infections
• Low blood cell counts
• Decreased of appetite
• Nausea, vomiting
• Diarrhea
• Swelling of lips and mouth
• Changes in taste
• Nose bleed
• Dry eye, blurred vision, increased tearing
Common Side Effects
• Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
• Lung inflammation (chest pain, dry cough, or difficulty breathing)
How To Use
Take Brespal 125 mg exactly as prescribed by your doctor. Your Healthcare Provider will decide your Brespal 125mg dosage. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Safety Advice
• Breast Feeding: It is not recommended to take Brespal 125 mg while breastfeeding as it is not known whether it passes into the breast milk.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Brespal 125 mg. Check with your doctor for advice.
• Liver: Inform your physician if you have any liver disorders before taking Brespal 125 mg, as it should be used with caution in liver disorder patients.
• Lungs: It is not unknown whether Brespal 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Brespal 125 mg can cause tiredness. Avoid driving if you are unwell
• Pregnancy: It is not recommended to take Brespal 125 mg during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.